Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BARINTHUS-BIOTHERAPEUTICS-122186771/news/Vaccitech-Doses-First-Patient-in-PCA001-a-Prostate-Cancer-Phase-1-2-Clinical-Trial-of-VTP-850-Immun-44091612/?utm_source=whatsapp&utm_medium=social&utm_campaign=share